These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 15039771)
1. Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Fantegrossi WE; Woolverton WL; Kilbourn M; Sherman P; Yuan J; Hatzidimitriou G; Ricaurte GA; Woods JH; Winger G Neuropsychopharmacology; 2004 Jul; 29(7):1270-81. PubMed ID: 15039771 [TBL] [Abstract][Full Text] [Related]
2. Estimating the relative reinforcing strength of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine. Wang Z; Woolverton WL Psychopharmacology (Berl); 2007 Jan; 189(4):483-8. PubMed ID: 17063335 [TBL] [Abstract][Full Text] [Related]
3. Reinforcing effects of methylenedioxy amphetamine congeners in rhesus monkeys: are intravenous self-administration experiments relevant to MDMA neurotoxicity? Fantegrossi WE Psychopharmacology (Berl); 2007 Jan; 189(4):471-82. PubMed ID: 16555062 [TBL] [Abstract][Full Text] [Related]
4. MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding. Schenk S; Hely L; Lake B; Daniela E; Gittings D; Mash DC Eur J Neurosci; 2007 Dec; 26(11):3229-36. PubMed ID: 18005064 [TBL] [Abstract][Full Text] [Related]
5. Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. Frederick DL; Ali SF; Slikker W; Gillam MP; Allen RR; Paule MG Neurotoxicol Teratol; 1995; 17(5):531-43. PubMed ID: 8551999 [TBL] [Abstract][Full Text] [Related]
6. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge. Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898 [TBL] [Abstract][Full Text] [Related]
7. 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement. Fantegrossi WE; Ullrich T; Rice KC; Woods JH; Winger G Psychopharmacology (Berl); 2002 Jun; 161(4):356-64. PubMed ID: 12073162 [TBL] [Abstract][Full Text] [Related]
8. Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat. Cassel JC; Riegert C; Rutz S; Koenig J; Rothmaier K; Cosquer B; Lazarus C; Birthelmer A; Jeltsch H; Jones BC; Jackisch R Neuropsychopharmacology; 2005 Oct; 30(10):1870-82. PubMed ID: 15785779 [TBL] [Abstract][Full Text] [Related]
9. Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles. Melega WP; Jorgensen MJ; Laćan G; Way BM; Pham J; Morton G; Cho AK; Fairbanks LA Neuropsychopharmacology; 2008 May; 33(6):1441-52. PubMed ID: 17625500 [TBL] [Abstract][Full Text] [Related]
10. MDMA elicits behavioral and neurochemical sensitization in rats. Kalivas PW; Duffy P; White SR Neuropsychopharmacology; 1998 Jun; 18(6):469-79. PubMed ID: 9571655 [TBL] [Abstract][Full Text] [Related]
11. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys. Insel TR; Battaglia G; Johannessen JN; Marra S; De Souza EB J Pharmacol Exp Ther; 1989 Jun; 249(3):713-20. PubMed ID: 2471824 [TBL] [Abstract][Full Text] [Related]
12. Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats. Morley KC; Cornish JL; Li KM; McGregor IS Pharmacol Biochem Behav; 2004 Oct; 79(2):331-42. PubMed ID: 15501310 [TBL] [Abstract][Full Text] [Related]
13. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats. Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443 [TBL] [Abstract][Full Text] [Related]
14. Reinforcing effects of synthetic cathinones in rhesus monkeys: Dose-response and behavioral economic analyses. de Moura FB; Sherwood A; Prisinzano TE; Paronis CA; Bergman J; Kohut SJ Pharmacol Biochem Behav; 2021 Mar; 202():173112. PubMed ID: 33444603 [TBL] [Abstract][Full Text] [Related]
15. Functional imaging and neurochemical correlates of stimulant self-administration in primates. Howell LL; Wilcox KM Psychopharmacology (Berl); 2002 Oct; 163(3-4):352-61. PubMed ID: 12373436 [TBL] [Abstract][Full Text] [Related]
16. Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys. Banks ML; Czoty PW; Gage HD; Bounds MC; Garg PK; Garg S; Nader MA Neuropsychopharmacology; 2008 Jan; 33(2):219-25. PubMed ID: 17443127 [TBL] [Abstract][Full Text] [Related]
17. In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys. Fantegrossi WE Exp Clin Psychopharmacol; 2008 Feb; 16(1):1-12. PubMed ID: 18266547 [TBL] [Abstract][Full Text] [Related]
18. Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment. Frederick DL; Ali SF; Gillam MP; Gossett J; Slikker W; Paule MG Ann N Y Acad Sci; 1998 May; 844():183-90. PubMed ID: 9668676 [TBL] [Abstract][Full Text] [Related]
19. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA). Slikker W; Ali SF; Scallet AC; Frith CH; Newport GD; Bailey JR Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631 [TBL] [Abstract][Full Text] [Related]
20. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. Clemens KJ; Van Nieuwenhuyzen PS; Li KM; Cornish JL; Hunt GE; McGregor IS Psychopharmacology (Berl); 2004 May; 173(3-4):318-25. PubMed ID: 15029472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]